Thursday 18th March, 2010   |   Welcome, guest. Please, login or register  
Tuesday October 20, 15:13

Do you use Alli?

According to a survey by the GlaxoSmithKline (GSK), 75% of people who use the pill for weight loss Alli are women. These users are aged 35 to 49 years (42%), 18 to 34 years (37%) and 50 to 65 years (21%). 85% of users of Alli are overweight.

37% of users have a body mass index (BMI) between 25 and 30, 30% are obese with a BMI between 30 and 35, and 18% have serious and massive obesity with a BMI of 35 to 40 and more.

100% of users of Alli took at least one system over the past five years: 3.3 in average.

These users take this pill to lose weight primarily to be healthy (56%) to have confidence (43%), to present a good image to others (33%), and for making food healthier (30% ).

51% bought Alli because the drug is available without prescription, 51% because it appeared more effective than another product, and 43% because it seemed suitable for their weight problem.

Since they use the pill, 60% have reduced the amount of fat in their diet, 37% consume more vegetables and 37% are snacking more between meals.

The Alli pill, marketed by GlaxoSmithKline (GSK), has been sold without prescription since May.

 
Rate:
  •  
Please, login to rate the article.
PrintBookmark and Share
 
 

Recommended articles:

 

H1N1 influenza: Buying drugs via the Internet may be dangerous, experts say

Beside the risk for health, buying drugs via the Internet enables cyber criminals to reap millions of dollars
Buy Tamiflu against the H1N1 influenza on the Internet. Nothing more simple and users are more likely to do so. Beside the risk for health it enables cyber criminals to reap millions of dollars.
 

The GBL, a fashionable trend that has devastating effects

Gamma-Butyrolactone (GBL): the relatively safe use may result in coma
Fashionable in recreational places, the GBL is not a prohibited substance, used as a solvent in industry, but its misuse can have devastating effects.
 

New promising treatment against hepatitis-C

Promising potential new treatment against hepatitis C
U.S. researchers have discovered a new substance that blocks the replication of hepatitis C, potentially paving the way for more effective treatments against this infection, the leading cause of liver cancer.
 

Most recent in the category Diet:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

Please, login to post comments.
 
 
 
 

Home | Social Health | AIDS | Cancer | Deseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2010 Heal-all.org. All rights reserved.